Exploring the multifunctional potential of designed benzothiazole hydrazones - 21/09/25
, Vera Bruggink c, 1
, Robert Klaus Hofstetter c
, Chiara Tupini b
, Leonardo Montani a
, Sofia Fagnani b
, Filippo Marchetti a
, Elisa Durini a
, Ilaria Lampronti b
, Silvia Vertuani a
, Anna Baldisserotto a, ⁎
, Oliver Werz c, ⁎
, Stefano Manfredini a 
Abstract |
The involvement of oxidative stress in the aetiology of various multifactorial diseases is well known, just as the design of multifunctional compounds is recognized as an innovative strategy to control complex-spectrum diseases. The purpose of this work was to synthesize a small library of six benzothiazole derivatives with hydrazonic spacers and to evaluate their multifunctional efficacy in terms of antioxidant, UV-filtering, antiproliferative, and anti-inflammatory activities. From the SAR study it emerged that the hydrazone linker, when coupled with a hydroxyl group in position 4 and another hydroxyl or methoxyl in position 3, seems to direct the profile of the molecule towards multifunctionality. The antitumor activity against melanoma cells seems to be related to the inhibition of tyrosinase (BZTidr10–12). All the compounds of the series have shown to be direct inhibitors of 5-lipoxygenase (5-LO). In particular, compound BZTidr12, with an IC50 of 0.03 µM, proved to be the most potent inhibitor of the series against isolated 5-LO activity in a cell-free assay.
Le texte complet de cet article est disponible en PDF.Highlights |
• | Multifunctional compounds are smart strategy for the treatment of multifactorial diseases. |
• | Benzothiazole derivatives were evaluated for UV-filtering, antioxidant, antinfiammatory and antiproliferative activities. |
• | BZTidr7–12 were promising multifunctional compounds. |
• | BZTidr12 (IC50 of 0.03 µM) proved to be the most potent inhibitor in the series against isolated 5-LO activity. |
Keywords : Antioxidant, Multifunctional, Anti-inflammatory, Skin-desease, Eterocycle
Plan
Vol 191
Article 118511- octobre 2025 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
